The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The development of vaccines: how the past led to the future
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Self-citationLai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
A VIRUS OBTAINED FROM INFLUENZA PATIENTS
Smith, W., Andrewes, C. H., & Laidlaw, P. P. (1933) · The Lancet · doi:10.1016/s0140-6736(00)78541-2 · Cited by 862
Systems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 749
Steere, A. C., Sikand, V. K., Meurice, F., Parenti, D. L., Fikrig, E., Schoen, R. T., Nowakowski, J., Schmid, C. H., Laukamp, S., Buscarino, C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390401 · Cited by 746
Human hepatitis B vaccine from recombinant yeast
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 739
Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren
(1890) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1207589 · Cited by 643
Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.2.361 · Cited by 625
Germanier, R., & Fiirer, E. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.5.553 · Cited by 523
Zhou, J., Sun, X. Y., Stenzel, D. J., & Frazer, I. H. (1991) · Virology · doi:10.1016/0042-6822(91)90772-4 · Cited by 506
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
Poxvirus genomes: a phylogenetic analysis
Gubser, C., Hué, S., Kellam, P., & Smith, G. L. (2004) · Journal of General Virology · doi:10.1099/vir.0.19565-0 · Cited by 406
7. Prevention of Pneumococcal Pneumonia by Vaccination
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., & Reid, R. D. W. (1985) · Life with the Pneumococcus · doi:10.9783/9781512800135-009 · Cited by 401
Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390402 · Cited by 397
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Liu, T. Y., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1349 · Cited by 396
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Goebel, W. F., & Avery, O. T. (1929) · Journal of Experimental Medicine · doi:10.1084/jem.50.4.521 · Cited by 283
Immunity in infective diseases
Metchnikoff, É., & Binnie, F. G. (1905) · University Press eBooks · doi:10.5962/bhl.title.29861 · Cited by 267
Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 256
Self-citationReexamination of the Protective Role of the Capsular Polysaccharide (Vi antigen) of Salmonella typhi
Robbins, J. D., & Robbins, J. B. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.3.436 · Cited by 247
VACCINATION AGAINST WHOOPING COUGH
MADSEN, T. (1933) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1933.02740280007003 · Cited by 243
Pneumococcal conjugate vaccines
ESKOLA, J., & ANTTILA, M. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199906000-00015 · Cited by 235
Bernstein, D. I., Sack, D. A., Rothstein, E., Reisinger, K., Smith, V. E., O'Sullivan, D., Spriggs, D. R., & Ward, R. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12106-2 · Cited by 232
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Avery, O. T., & Goebel, W. F. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.54.3.437 · Cited by 220
Development of a live attenuated varicella vaccine.
Takahashi, M., Okuno, Y., Otsuka, T., Osame, J., & Takamizawa, A. (1975) · PubMed · doi:10.18910/82655 · Cited by 203
An Inquiry into the Causes and Effects of the Variolae Vaccinae
Jenner, E. (2023) · Scientific and Medical Knowledge Production, 1796-1918 · doi:10.4324/9781003009337-8 · Cited by 201
Formaldehyde Treatment and Safety Testing of Experimental Poliomyelitis Vaccines
Salk, J. E., Krech, U., Youngner, J. S., Bennett, B. L., Lewis, L. J., & Bazeley, P. L. (1954) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.44.5.563 · Cited by 183
Live, Attenuated Mumps-Virus Vaccine
Hilleman, M. R., Buynak, E. B., Weibel, R. E., & Stokes, J. (1968) · New England Journal of Medicine · doi:10.1056/nejm196802012780501 · Cited by 179
Sato, Y., Izumiya, K., Sato, H., Cowell, J. L., & Manclark, C. R. (1981) · Infection and Immunity · doi:10.1128/iai.31.3.1223-1231.1981 · Cited by 176
Development and characterization of cold-adapted viruses for use as live virus vaccines
Maassab, H. F., & DeBorde, D. C. (1985) · Vaccine · doi:10.1016/0264-410x(85)90124-0 · Cited by 172
STUDIES ON VARIANTS OF POLIOMYELITIS VIRUS
Sabin, A. B., Hennessen, W., & Winsser, J. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.6.551 · Cited by 155
Tulman, E. R., Delhon, G. A., Afonso, C. L., Lu, Z., Zsak, L., Sandybayev, N. T., Kerembekova, U. Z., Zaitsev, V. L., Kutish, G. F., & Rock, D. L. (2006) · Journal of Virology · doi:10.1128/jvi.00945-06 · Cited by 146
History of Vaccine Development
Plotkin, S. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1339-5 · Cited by 135
Self-citationKoprowski, H., JERVIS, G. A., & Norton, T. W. (1952) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119499 · Cited by 129
Attenuation of RA 27/3 Rubella Virus in WI-38 Human Diploid Cells
Plotkin, S. A., Farquhar, J. D., Katz, M., & Buser, F. (1969) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1969.02100040180004 · Cited by 128
Self-citationStudies on an Attenuated Measles-Virus Vaccine
Katz, S. L., Kempe, C. H., Black, F. L., LEPOW, M. L., D, S. K. M., Haggerty, R. J., & Enders, J. F. (1960) · New England Journal of Medicine · doi:10.1056/nejm196007282630408 · Cited by 115
An inactivated hepatitis A viral vaccine of cell culture origin
PROVOST, P. J., Hughes, J. V., Miller, W. J. W., Giesa, P. A., Banker, F. S., & Emini, E. A. (1986) · Journal of Medical Virology · doi:10.1002/jmv.1890190105 · Cited by 111
EVALUATION OF RED CROSS GAMMA GLOBULIN AS A PROPHYLACTIC AGENT FOR POLIOMYELITIS
Hammon, W. M. (1952) · JAMA · doi:10.1001/jama.1952.03680080019003 · Cited by 105
Vaccine discovery and translation of new vaccine technology
Rappuoli, R., BLACK, S. B., & Lambert, P. H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60440-6 · Cited by 105
Diphtheria Toxoid as an Immunising Agent
Glenny, A. T., & Hopkins, B. E. (1923) · PubMed Central · Cited by 96
INVESTIGATION ON VOLUNTEERS INFECTED WITH THE INFLUENZA VIRUS
Smorodintseff, A. A., TUSHINSKII, M. D., Drobyshevskaya, A. I., Korovin, A. A., & Osetroff, A. I. (1937) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193708000-00002 · Cited by 93
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants
Clark, H. F., Offit, P. A., Plotkin, S. A., & Heaton, P. M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220283.58039.b6 · Cited by 83
Self-citationModification of the virulence of yellow fever virus by cultivation in tissues in vitro
Lloyd, W., Theiler, M., & Ricci, N. I. (1936) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(36)90002-0 · Cited by 78
Parke, J. C., Schneerson, R., Robbins, J. B., & Schlesselman, J. J. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement.s51 · Cited by 74
Experimental Live Attenuated Rubella Virus Vaccine: Clinical Evaluation of Cendehill Strain
Prinzie, A. (1969) · American journal of diseases of children · doi:10.1001/archpedi.1969.02100040174003 · Cited by 66
EVALUATION OF RED CROSS GAMMA GLOBULIN AS A PROPHYLACTIC AGENT FOR POLIOMYELITIS
Hammon, W. M. (1954) · JAMA · doi:10.1001/jama.1954.02950010023009 · Cited by 56
Experimentelle Untersuchungen zur Frage der Schutzimpfung des Menschen gegen Typhus abdominalis
Pfeiffer, R., & Kölle, W. (1896) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1204734 · Cited by 53
Remarks on the Plague Prophylactic Fluid
Haffkine, W. M. (1897) · BMJ · doi:10.1136/bmj.1.1902.1461 · Cited by 50
Development of Smallpox Vaccine in England in the Eighteenth and Nineteenth Centuries
Didgeon, J. A. (1963) · BMJ · doi:10.1136/bmj.1.5342.1367 · Cited by 44
Vaccination of Human Subjects with Virus of Human Influenza
Thomas, F., & Magill, T. P. (1936) · Experimental Biology and Medicine · doi:10.3181/00379727-33-8467p · Cited by 42
(1985) · PubMed · Cited by 14
Monath, T. P. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1339-5_14 · Cited by 6
Bacterial Polysaccharide Vaccines
AUSTRIAN, R. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1339-5_11 · Cited by 6
Cited by
Kawecki, T. J., Lenski, R. E., Ebert, D., Hollis, B., Olivieri, I., & Whitlock, M. C. (2012) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2012.06.001 · Cited by 807
Plotkin, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400472111 · Cited by 642
Self-citationmRNA vaccines manufacturing: challenges and bottlenecks
Rosa, S. S., Prazeres, D. M. F., Azevedo, A. M., & Marques, M. P. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.038 · Cited by 545
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Vaccines, new opportunities for a new society
Rappuoli, R., Pizza, M., Del Giudice, G., & De Gregorio, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402981111 · Cited by 335
Metadata
- Authors
- Plotkin, S. A., & Plotkin, S. L.
- Venue
- Nature Reviews Microbiology
- Published
- 2011-10-03
- Volume
- 9
- Issue
- 12
- Pages
- 889-893
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2067909449
- Cited by
- 333
- References
- 58
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.